WebAccula RSV Test Cassette. The Accula RSV Test is a sample-to-answer molecular diagnostic test utilizing polymerase chain reaction (PCR) technology that provides … Web8 feb. 2024 · Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2024 to 2027" report has been added to ResearchAndMarkets.com's offering. COVID-19 …
Table 1. Manufacturer-quoted information on molecular point …
WebThe Accula™ SARS-CoV-2 Test performed on the Accula Dock or the Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral … Web19 jan. 2024 · It has developed and markets a PCR-based rapid point-of-care testing platform for infectious diseases, including SARS-CoV-2 (COVID-19), flu A and B, respiratory syncytial virus (RSV) and Strep A. Mesa has about 500 employees and in 2024 reported revenue of about $45 million. bundle clean
Thermo Fisher Buys Mesa Biotech – PharmaLive
Web11 jun. 2024 · - Quantitative PCR (qPCR): highly sensitive, widely available and current standard GeneSystems, Surescreen Diagnostics capture binding - Droplet digital PCR (ddPCR): absolute quantification, 5-plex, reference not needed • Developers: Roche, LabCorp, PerkinElmer (RUO), Mesa Biotech, Cepheid, Qiagen, RT-LAMP 2. Serological … WebThe Accula PCR-based system received Emergency Use Authorization from the FDA for SARS-CoV-2 in vitro diagnostic testing and has received 510 (k) clearance for Flu A/B, … Web12 apr. 2024 · Digital PCR Market to Reach US$ 403.8 million by 2033, ... Thermo Fisher Scientific, Inc. acquired Mesa Biotech, Inc., a developer of point-of-care molecular diagnostic tests, to expand its product portfolio and … bundle clip ins